| Comparison of normalization approaches for gene expression studies completed with high-throughput sequencing F Abbas-Aghababazadeh, Q Li, BL Fridley PloS one 13 (10), e0206312, 2018 | 88 | 2018 |
| Assessment of ASC specks as a putative biomarker of pyroptosis in myelodysplastic syndromes: an observational cohort study AA Basiorka, KL McGraw, F Abbas-Aghababazadeh, AF McLemore, ... The Lancet Haematology 5 (9), e393-e402, 2018 | 47 | 2018 |
| Oxidized mitochondrial DNA released after inflammasome activation is a disease biomarker for myelodysplastic syndromes GA Ward, KL McGraw, F Abbas-Aghababazadeh, BS Meyer, ... Blood advances 5 (8), 2216-2228, 2021 | 30 | 2021 |
| Prospective CYP2C19‐Guided Voriconazole Prophylaxis in Patients With Neutropenic Acute Myeloid Leukemia Reduces the Incidence of Subtherapeutic … JK Hicks, RE Quilitz, RS Komrokji, TE Kubal, JE Lancet, Y Pasikhova, ... Clinical Pharmacology & Therapeutics 107 (3), 563-570, 2020 | 29 | 2020 |
| Leveraging Big Data of Immune Checkpoint Blockade Response Identifies Novel Potential Targets Y Bareche, D Kelly, F Abbas-Aghababazadeh, M Nakano, ... Annals of Oncology, 2022 | 28 | 2022 |
| Statistical and bioinformatics analysis of data from bulk and single-cell RNA sequencing experiments X Yu, F Abbas-Aghababazadeh, YA Chen, BL Fridley Translational Bioinformatics for Therapeutic Development, 143-175, 2021 | 25 | 2021 |
| Statistical genomics in rare cancer F Abbas-Aghababazadeh, Q Mo, BL Fridley Seminars in cancer biology 61, 1-10, 2020 | 20 | 2020 |
| Parametric estimation of the local false discovery rate for identifying genetic associations Y Yang, FA Aghababazadeh, DR Bickel IEEE/ACM Transactions on Computational Biology and Bioinformatics 10 (1), 98-108, 2012 | 18 | 2012 |
| Prediction of human papillomavirus (HPV) association of oropharyngeal cancer (OPC) using radiomics: The impact of the variation of CT scanner R Reiazi, C Arrowsmith, M Welch, F Abbas-Aghababazadeh, C Eeles, ... Cancers 13 (9), 2269, 2021 | 17 | 2021 |
| A crowdsourced analysis to identify ab initio molecular signatures predictive of susceptibility to viral infection S Fourati, A Talla, M Mahmoudian, JG Burkhart, R Klén, R Henao, T Yu, ... Nature communications 9 (1), 4418, 2018 | 16 | 2018 |
| Nonlinear mixed-effects models for modeling in vitro drug response data to determine problematic cancer cell lines F Abbas-Aghababazadeh, P Lu, BL Fridley Scientific reports 9 (1), 14421, 2019 | 10 | 2019 |
| Expression of sestrin genes in radiotherapy for prostate cancer and its association with fatigue: A proof-of-concept study VJ Gonzalez, F Abbas-Aghababazadeh, BL Fridley, T Ghansah, ... Biological research for nursing 20 (2), 218-226, 2018 | 10 | 2018 |
| Heterogeneity in leukemia cells that escape drug-induced senescence-like state D Miller, K Kerkhofs, F Abbas-Aghababazadeh, SS Madahar, MD Minden, ... Cell Death & Disease 14 (8), 503, 2023 | 3 | 2023 |
| Estimating the local false discovery rate via a bootstrap solution to the reference class problem F Abbas-Aghababazadeh, M Alvo, DR Bickel Plos one 13 (11), e0206902, 2018 | 3 | 2018 |
| Translational Bioinformatics for Therapeutic Development J Markowitz Humana Press, 2021 | 2 | 2021 |
| A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trials A Hernando-Calvo, M Vila-Casadesús, Y Bareche, A Gonzalez-Medina, ... Med 4 (10), 710-727. e5, 2023 | 1 | 2023 |
| Predictors of residual disease after debulking surgery in advanced stage ovarian cancer F Abbas-Aghababazadeh, N Sasamoto, MK Townsend, T Huang, ... Frontiers in Oncology 13, 106, 2023 | 1 | 2023 |
| The impact of violating the independence assumption in meta-analysis on biomarker discovery F Abbas-Aghababazadeh, W Xu, B Haibe-Kains Frontiers in Genetics, 3502, 2023 | 1 | 2023 |
| Meta-analysis of preclinical pharmacogenomic studies to discover robust and translatable biomarkers of drug response P Smirnov, SK Nair, F Abbas-Aghababazadeh, N Feizi, I Smith, TJ Pugh, ... bioRxiv, 2022.10. 22.513279, 2022 | 1 | 2022 |
| Oxidized mitochondrial DNA is a catalyst and biomarker of pyroptotic cell death in myelodysplastic syndromes GA Ward, KL McGraw, AF McLemore, F Abbas-Aghababazadeh, HA Hou, ... Blood 132, 3076, 2018 | 1 | 2018 |
